Skip to search formSkip to main contentSkip to account menu

BMY 28232

Known as: BMY-28232 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cephalosporins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Antimicrobial activity and beta-lactamase stability of BMY-28232, parent compound of an oral cephalosporin
BMY-28232, an aminothiazolyl imino methoxy cephalosporin which is available as an orally absorbed acetoxyethyl ester, inhibited… 
1990
1990
Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester
BMY-28271, the acetoxyethyl ester of BMY-28232, 7-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3(Z) -propen-1-yl-3… 
1989
1989
In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters
The in vitro activity of a new cephalosporin, BMY-28232 (7-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-[ (Z)-1… 
1989
1989
Preliminary in-vitro studies of BMY-28232, the active metabolite of the BMY-28271 cephalosporin ester.
1988
1988
Synthesis and biological activity of a new cephalosporin, BMY-28232 and its prodrug-type esters for oral use.
The synthesis and structure-activity relationships of 7-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-[( Z)-1- propenyl… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)